FDA-Regulated Medical Products Using the Internet and Social Media Tools

For additional information see the links to the FDA transcripts below:

Promotion of FDA Regulated Medical Products Using the Internet and Social Medial Tools, Part 15 Public Hearing - November 12, 2009 Transcript

Promotion of FDA Regulated Medical Products Using the Internet and Social Medial Tools, Part 15 Public Hearing - November 13, 2009 Transcript

Original hearing information:

Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools

National Transportation Safety Board Conference Center

429 L’Enfant Plaza, SW., Washington DC, 20594

The Food and Drug Administration (FDA) will hold a public hearing to provide an opportunity for broad public participation and comment on promotion of FDA-regulated medical products (including prescription drugs for humans and animals, prescription biologics, and medical devices) using the Internet and social media tools.  FDA is seeking participation in the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, Internet vendors, advertising agencies, and the regulated industry.  This meeting and written comments are intended to help guide FDA in making policy decisions on the promotion of human and animal prescription drugs and biologics and medical devices using the Internet and social media tools.  FDA is seeking input on a number of specific questions but is interested in any other pertinent information participants in the hearing would like to share.

Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools

Comments

[e cigarettes]

I am really losing all faith and credibility in the FDA. It seems to me they are being influenced by corporate agenda and special interest. I take everything they say with a grain of salt.

[Danny DeMichele]

FDA is seeking input on a number of specific questions but is interested in any other pertinent information participants in the hearing would like to share.

[Pot]

I think this is a good move from FDA so that they can monitor as well those regulated products that are sold on the internet. With they can here out all parties involved from the user, patients and other agencies.